Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 130.50
+1.00 (0.77%)
At close: Jun 18, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.83 billion as of June 18, 2026. Its market cap has increased by 126.17% in one year.
Market Cap
6.83B
Enterprise Value
6.50B
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
130.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.83B, an increase of 227.01%. That is a compound annual growth rate of 10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 6.83B | 19.27% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 13.38B |
| TCM Biotech International | 9.00B |
| Libo Pharma | 2.71B |
| Anbogen Therapeutics | 2.25B |
| TEH SENG Pharmaceutical Mfg. | 2.02B |
| Timing Pharmaceutial | 1.73B |
| TSA International | 1.67B |
| Protect Animal Health | 1.62B |